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Abstract—A perturbed gut microbiome has recently been 
linked with multiple disease processes, yet researchers currently 
lack tools that can provide in vivo, quantitative, and real-time 
insight into these processes and associated host-microbe 
interactions. We propose an in vivo wireless implant for 
monitoring gastrointestinal tract redox states using oxidation-
reduction potentials (ORP). The implant is powered and 
conveniently interrogated via ultrasonic waves. We engineer the 
sensor electronics, electrodes, and encapsulation materials for 
robustness in vivo, and integrate them into an implant that 
endures autoclave sterilization and measures ORP for 12 days 
implanted in the cecum of a live rat. The presented implant 
platform paves the way for long-term experimental testing of 
biological hypotheses, offering new opportunities for 
understanding gut redox pathophysiology mechanisms, and 
facilitating translation to disease diagnosis and treatment 
applications. 
Index Terms—implantable devices, implant sensors, wireless, 
redox potential, oxidation-reduction potential, ORP, gut, GI-
tract, gastrointestinal, microbiome. 
I. INTRODUCTION 
 The human large intestine harbors trillions of microbes that 
interact with one another and the host. Identifying which 
microbial compositions (“microbiomes”) promote health or 
disease is one of the grand challenges of the field. Different 
microbiomes produce different chemical environments in the 
intestine [1], [2] but how these microbiome-mediated chemical 
environments impact host physiology and health status are 
unclear. An emerging hypothesis is that disease-associated 
microbiomes share a common feature: an altered chemical 
landscape in the gut with a higher level of environmental 
oxidation [3]–[7].  
 Evidence for this hypothesis comes from multiple 
different systems. First, Salmonella and Citrobacter 
pathogens encourage inflammation in the host to promote 
an oxidative environment. This oxidative environment 
contains more terminal electron acceptors for direct use in 
respiration [8], [9] and produces new carbon substrates 
that are more readily catabolized by these pathogens [10], 
[11]. The oxidant-supported outgrowth of these 
aerotolerant pathogens potentiates inflammation, toxic 
metabolite production and impairs barrier function [5]; if 
the host immune response cannot control the pathogens, 
chronic inflammation ensues and positive feedback 
prevents recolonization with a healthy microbiome [12]. 
Second, depletion of butyrate production (along with 
other short-chain fatty acids [SCFAs]) in the gut is 
associated with expansion of pathogens and dysbiosis 
[13], [14]. The mechanisms are complex, but oxidant 
balance plays a key role: without colonic butyrate, 
colonocytes reduce beta-oxidation, leading to increased 
aerobicity in the gut [15], [16]. Finally, soil and seafloor 
microbial communities are structured by gradients in 
environmental oxidation state and the availability of 
terminal electron acceptors and donors [17]–[19]. 
Disturbances in the redox balance of these environments 
can impair function [20] in an analogous manner to redox 
balance in the gut.   
 Unfortunately, testing this oxidation hypothesis 
directly is currently impossible because no in vivo, 
longitudinal, oxidation-measuring sensor exists for 
research animals (e.g. mice and rats). Battery-powered 
capsules for human ingestion have been demonstrated for 
applications such as gas (e.g. oxygen, CO2), pH, 
bioluminescence sensing and more [21]–[23]. However, 
capsule size is limiting for use in model organisms where 
biological hypotheses can be directly and conveniently 
tested (e.g. through dietary change, antibiotic treatment, or 
genetic alteration of host or microbe). Ingestible capsules 
also transit the gut rapidly, typically within 24 to 48 hours 
in humans [24], [25], prohibiting location-specific and 
longitudinal tracking of changes in gut microbiome states 
which occur over longer time frames [26], [27]. We 
propose an implantable device as a platform for extended 
and on-demand gut sensing in small animals. In this 
paper, we design such an implant sensor using oxidation-
reduction potentials (ORP) as a measurement modality. 
ORP is an integrated measure of an environment’s 
propensity to lose or gain electrons and has been used to 
explain microbial energetics and ecology primarily in 
environmental contexts [17], [28]. As outlined above, 
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evidence suggests diet and antibiotic-induced dysbiosis 
changes the energetic landscape of the gut, substantially 
increasing the concentration of high-potential terminal 
electron acceptors (oxidants) like oxygen, reactive oxygen 
and reactive nitrogen species (ROS/RNS) [5], [13]. 
Recent work has applied ORP sensing to fecal samples 
from mice, demonstrating significant ORP changes due to 
antibiotics [6], but the relevance of fecal ORP to gut 
physiological conditions is unclear. An internal real-time 
ORP measurement using an implantable sensor has not 
been demonstrated. Towards this goal, we design a 
prototype ORP sensor comprising a custom CMOS IC 
with ultrasonic, wireless power up and telemetry, robust 
biocompatible packaging for longevity in the harsh gut 
environment, and solid-state ORP electrodes. In the 
following sections, we outline the underlying theory of 
operation, the design and in vitro characterization of the 
sensor components, and the interaction of electronics and 
electrodes in biological media. We conclude this paper 
with a proof-of-concept 12-day in vivo measurement of 
the fully integrated and encapsulated sensor in a rat. 
 
II. PRINCIPLE OF OPERATION 
 The principle of operation of the proposed redox 
sensor is shown in Fig. 1. The sensor is surgically 
implanted in the cecum of a rodent; while multiple sites 
for implantation are possible, the cecum contains the 
majority of bacteria in the rodent by mass, and is thus 
most attractive for understanding host-microbe 
interactions [29]. An external transducer placed in contact 
with the body sends power via ultrasonic waves to the 
sensor on demand. The sensor harvests the received 
power, measures the ORP, and transmits ultrasound back 
representing the measured data.   
 The ultrasonic link used for power delivery and data 
transmission relies on far-field radiative power transfer, 
allowing the external transducer and implant transceiver 
to be designed separately [30], [31]. In this work we use a 
commercial single-element ultrasound probe for the 
external device and focus on the design of the implant.  
We utilize ultrasonic links because they allow high 
acoustic-electrical efficiency with mm-sized transducers 
and exhibit lower tissue attenuation (~0.5-1 dB/cm/MHz) 
than other methods such as RF/inductive powering [32], 
[33]. These advantages allow for reliable and safe 
operation in rodents (well below the FDA diagnostic 
ultrasound intensity limit, 7.2 mW/mm2), while enabling 
scalability to larger animals and future translational 
studies.  
 ORP is a potential difference developed between the 
sensor electrodes as a result of spontaneous redox 
reactions of luminal chemical species. ORP electrodes 
consist of an inert metal indicator/working electrode, in 
this case a platinum wire, and a reference electrode. In a 
complex chemical environment such as the gut, ORP is 
approximated as the weighted sum of all potentials of 
redox couples present [28]. The resulting potential 
difference (working electrode minus reference) for m 
redox couples can be expressed as, [28],  
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where   
  is the electron exchange current for each couple, 
 ℎ 
  is the individual couple redox potential at standard 
state,   is the gas constant,   is absolute temperature,    
is the number of electrons exchanged for each reaction,   
is the Faraday constant, (    ), (   ), ( 
 ) are the 
activities of reductants, oxidants and hydrogen ions 
respectively, and α is the number of protons exchanged. 
Thus, an ORP measurement captures a ‘snapshot’ of the 
oxidation-reduction profile of an environment that is 
predominantly shaped by the most abundant redox 
couples. In a healthy rat cecum, ORP with respect to a 
silver/silver chloride (Ag/AgCl) reference electrode has 
been reported in the range of -500 mV to -100 mV1 [34]–
[36]. The more negative ORP is (the lower the working 
electrode potential), the greater the tendency of the 
chemical species in the medium to gain electrons (become 
reduced); therefore this range suggests the cecum is a 
strongly reducing environment, which is consistent with 
the lack of high-potential oxidants under normal 
conditions. While no electrode is truly inert or unbiased, 
the use of platinum in this sensor allows us to broadly 
capture the chemical species contributing to ORP in the 
gut, including oxidants like O2 and ROS/RNS [17].  
 
1 Note that Wostmann and Bruckner-Kardoss [35] and Schröder et al. [36] 
report ORP ( ℎ) with respect to the standard hydrogen electrode, resulting in 
an approx. +200mV offset from measurements with an Ag/AgCl reference, 
such as the ones we report in this work. They also normalize to pH 7; while 
ORP depends on pH, the correction factor depends on the specific oxidation-
reduction system [34]. Since the cecum is an unknown system, we did not 
apply a correction factor in our measurements. 
Fig. 1: Conceptual description of redox sensor operation. The sensor is 
wirelessly powered and measures the balance of oxidants and reductants 
(the ORP) produced by the interplay of host, microbe, and diet.  
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III. METHODS AND RESULTS 
 The implant sensor consists of three main components 
(Fig. 2a): electrodes for measuring ORP, encapsulation 
materials, and electronics including an ultrasonic 
piezoelectric transceiver (piezo) and an integrated circuit 
(IC) for ORP readout and wireless telemetry.  
A. Electrodes 
 An ideal reference electrode maintains a stable 
potential despite externally varying chemical conditions. 
Commercial ORP systems typically employ an Ag/AgCl 
reference electrode with a large volume of liquid 
electrolyte - a ‘tank’ (e.g. a Sigma-Aldrich Ag/AgCl 
electrode has 1-5 ml of 3 M KCl). This excess volume of 
[Cl-] ions nearly eliminates loss due to leakage across 
environmentally varying [Cl-] concentration gradients, 
ensuring a constant reference potential [37], [38]. 
Unfortunately, this type of electrode is challenging to 
adapt to the requirements of our sensor, due to the limited 
volume available. An alternative solution suited to size 
constraints is a solid-state reference electrode. Solid-state 
electrodes typically consist of an Ag wire covered by 
AgCl coating encapsulated in a polymer impregnated with 
KCl. They are designed to allow minimal ionic flow and 
prevent electrolyte leakage [37], [38]. Here we used solid-
state electrodes (Refex Ltd, referred to as ‘Refex’) made 
of a silver wire, the tip of which is chloridised and 
covered with a KCl-doped vinyl ester resin [39]. In all 
tests we used a platinum (purity 99.99%) wire as the 
working electrode, with both platinum and Refex wire 
having diameter of 0.38 mm and length 7 mm.  
 To assess accuracy we compared ORP measured by 
Refex electrodes to those of a Sigma-Aldrich standard 
reference double junction Ag/AgCl electrode using a high 
impedance SympHony SB70P pH meter in ORP mode 
(Fig. 3a). Since the complete sensor must undergo 
sterilization before in vivo implantation, the Refex 
electrodes were sterilized with a standard autoclave cycle 
(121 °C for 15 minutes in 2.8 M KCl) prior to use. After a 
12-hour rehydration period in 2.8 M KCl, Refex and 
platinum electrode pairs were placed in standard ORP 
calibration solutions (Light’s solution, Zobell’s solution, 
and modified Zobell’s). Between solution immersions, 
electrodes were wiped dry to avoid cross-contamination. 
The developed voltage was recorded for 2 minutes and the 
average was taken. The Refex electrodes withstand 
sterilization and measure the ORP to within 15 mV of the 
commercial reference system with < 2% deviation in 
slope. 
Next, we tested the dependence of the measured ORP 
on [Cl-] for Refex electrodes to determine how sensitive 
they would be to cecal changes in [Cl-] (Fig. 3b). An 
Ag/AgCl electrode with an infinite ‘tank’ should show no 
dependence on [Cl-] [40], while a Ag/AgCl electrode 
without any electrolyte volume (pseudo-reference) has an 
ideal response of approximately 59 mV change per decade 
change in [Cl-] based on the Nernst equation at room 
temperature. In this experiment, true Ag/AgCl gel-based 
reference electrodes (REDOX ORP-14, PCE Instruments) 
were immersed in constantly stirred KCl solutions with 
either a Refex or an Ag/AgCl pseudo-reference as counter 
electrode (see supplemental note A “Materials”, and Fig. 
3c). We performed multiple iterations of this experiment 
in short and longer time scales and measured the potential 
difference using a high impedance ORP meter (PCE-228-
R, PCE Instruments). Minute-long immersions of Refex 
(after 12 hours of hydration in 2.8 M KCl) showed the 
electrodes maintain a stable potential over two decades of 
[Cl-] change. Over longer time scales (24 hours), while the 
pseudo-reference electrodes show a Nernstian response as 
expected, the Refex show a sub-Nernstian response, with 
an average slope for two electrodes of 11 to 14 
mV/decade. We repeated this experiment with four Refex 
cycled through mixtures of 50% PBS 1X and 50% KCl 
0.01 to 1 M (the total [Cl-] concentrations were calculated 
based on standard PBS values; see supp. section A). Here 
the Refex electrodes show a more complex behaviour, 
with chloride concentrations near 0.1 M resulting in 
comparable values but concentrations near 1 M deviating 
to higher values than the previous experiment. Human 
intestinal concentrations of [Cl-] are described over a 
range of physiological concentrations and appear to range 
between 50-150 mM [41]–[44]. Thus, assuming the 
response evident in 24-hour KCl incubations (Fig. 3b), 
ORP readings from Refex electrodes would vary < 7 mV 
due to physiological changes in chloride concentrations. 
For experiments spanning more than 24 hours, it is 
expected the Refex electrodes will approach a Nernstian 
response similar to a pseudo-reference Ag/AgCl due to 
loss of chloride ions in the polymeric matrix. This would 
result in a worst-case variation of approx. 30 mV in the 
Fig. 2: a) Photograph of the designed and fabricated redox implant, and 
breakdown of its construction. b) Simplified system block diagram. 
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gut. Other sources of variance in biological ORP readings 
are substantially greater than 7-30 mV suggesting Refex 
electrodes are well-suited for capturing the relevant redox 
biology occurring in the cecum2. The accuracy over time 
of these solid-state electrodes could be improved with a 
thicker layer of KCl-doped resin with the trade-off of 
longer hydration time required [45].  
  
B. Electronics 
 The goal of the electronics is to provide reliable 
sampling of ORP as well as wireless power up and 
communication capabilities. Wireless sensor implants 
often use analog circuitry and passive telemetry schemes 
(e.g. backscattering) [46], [47]; while their development 
and operation are simpler allowing for miniaturization, 
they lack digital precision and can be susceptible to signal 
loss when operating in attenuative tissue. Conversely, we 
use a custom-fabricated chip (TSMC CMOS 180nm HV) 
with an active uplink and 10-bit analog-to-digital 
conversion to maintain robustness and precision over 
long-term in vivo operation; the design of the IC has been 
detailed in previous work [32].  
 A simplified block diagram of the electronics is shown 
in Fig. 2b. The IC primarily comprises a power 
management unit (PMU), an analog front-end (AFE), a 
10-bit Analog to Digital Converter (ADC) and a digital 
data transmitter (TX). The power consumption breakdown 
is shown in supplemental Fig. S1. The IC is wirelessly 
powered via ultrasonic waves, captured by the designed 
piezo, which initially serves as the acoustic to electrical 
power transducer. The system is designed to operate in 
bursts, allowing for on-demand sampling of the ORP at 
desired intervals. The onset of incoming ultrasound is 
detected using the PMU, and the electrical power from the 
piezo is rectified and stored in an off-chip storage 
capacitor. After an initialization phase, the AFE samples 
the ORP voltage input generated by the two electrodes. 
The AFE has been modified using a scaling network to 
sample ORP in the range of -500 mV to 300 mV, which 
covers the expected range in the gut [34], [35]  and allows 
measurement of common ORP calibration standards. 
Since the AFE is originally designed for general purpose 
voltage sampling, we considered its input resistance and 
leakage current (Fig. S2) and their effect on our 
measurement accuracy, which we discuss in section 
“Tests in fecal media and electronics input resistance”. 
After the AFE samples an input voltage, the sample is 
digitized by the ADC with sub-mV resolution, encoded 
using on-off keying (OOK) modulation and transmitted by 
a power amplifier (PA) in the TX block. OOK is used for 
 
2 Older literature [34]–[36] reported ORP measurements of > 10 minutes in 
length, with > 100 mV variations. Newer literature has reported the mean of 3-
minute readings with > 100 mV standard deviations [6]. 
simplicity of implementation and for energy savings, as 
the PA is turned off for transmission of bit 0. The 
modulated data is sent through the piezo, finally serving 
as an electrical to acoustic power transducer. The implant 
then powers off and waits for the next ultrasound power 
burst. To enable high temporal resolution, the power burst 
period and thus the sampling period is set to 1 ms for all 
measurements in this paper; since this parameter is 
externally controlled, it can be increased if needed to trade 
off measurement resolution with reduced average power 
dissipation. 
 The piezo utilized in this implant is a 1.1 x 1.1 x 1.8 
mm3 PZT5A cube. Note that the same piezo is used for 
both uplink and power up through time domain 
multiplexing, saving area. We have previously extensively 
investigated the design of piezo transceivers for many 
sensing applications [32], [48]–[50]. In this application, 
the frequency range of operation for the power up as well 
as wireless data communication is 790-840 kHz. At these 
frequencies, the link loss through tissue is < 1 dB/cm [33]. 
The dimensions and material of the piezo are chosen to 
place this frequency range in the piezo inductive region 
[48]. In this region the piezo has a positive reactance, 
allowing us to use a series capacitor with a small area 
footprint to optimize the impedance. The desired piezo 
resistance was 10 to 30 kΩ in this work, to allow for both 
> 40% efficient power up (see supp. section B 
“Ultrasound transmission and data recovery” for more 
details) and as well as approximately 80 μW to 230 μW 
output power from the IC power amplifier [32]. Power 
levels in the 100 μW range have been shown to be 
sufficient for transmission through 12 cm of tissue 
phantom, resulting in high signal-to-noise ratio (SNR) at 
the external receiver [32]. Here, the transmission distance 
is much lower (~1 cm maximum in the body), allowing 
for margin in case of misalignment and other unexpected 
sources of loss.  
 In vitro electronics characterization was first 
performed to characterize the wireless ultrasonic 
powering and data communication at a controlled depth, 
as well as the correct sampling and digitization of input 
voltages (Fig. 3d, 3e). The setup (Fig. 3f; details in supp. 
section B) uses a custom acrylic-constructed tank filled up 
to 1 cm from the tank bottom with mineral oil; mineral oil 
is used to model the acoustic impedance of soft tissue [51] 
and 1 cm is chosen based on the maximum expected 
implant depth in tissue. An implant before encapsulation, 
consisting of the IC, piezo and other surface-mount 
components, was placed in the measurement tank bottom. 
Soldered wires at the AFE input terminals, extending 5 
cm, allowed us to interface with standard ORP electrodes 
external to the tank. Tests were performed by immersing 
the electrodes in Zobell’s and Quinhydrone (saturated in 
pH 7 buffer) standard solutions; to achieve a negative 
ORP the electrode terminals were switched and for a zero-
voltage calibration point the leads were shorted together. 
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A focused single-element external ultrasound transducer 
was used to transmit ultrasound power to the implant 
piezo; the same transducer captured ultrasound signals 
from the piezo. The average output sensor code 
throughout 2 minutes of measurement was compared to 
the corresponding reading from a high-impedance ORP 
meter connected to the same electrodes. Fig. 3d (in blue) 
shows the measured ORP, indicating that the sensor 
backend output is linear (R2 = 0.9975) to ORP measured 
with a commercial meter. An example of received sensor 
data (10-bit message representing measured ORP, 
preceded by a ‘10’ preamble) with this setup is shown in 
Fig. 3e validating the wireless performance; the received 
SNR is ~30 dB enabling reliable data interpretation. Note 
that data reported in Figs. 3d, 3e, 5d, and 5e, are from the 
same sensor tracked throughout the fabrication and testing 
process.   
 To verify the insensitivity of the electronics to 
electrode properties and packaging, the implant board - 
after connection to a pair of custom electrodes and 
complete encapsulation (described in the “Fabrication and 
encapsulation” section) - was placed in two calibration 
solutions: Quinhydrone in pH 7 and pH 12 buffer. The 
setup used for this measurement (Fig. S3) was similar. 
The external transducer for powering and interrogating the 
sensor was immersed in the ORP calibration medium of 
interest at a distance of 1 cm. The resulting post-
packaging measurement (in red) is overlaid with the pre-
packaging measurement in Fig. 3c. The pre-encapsulation 
measurement uses a pair of standard electrodes, whereas 
the post-encapsulation sensor uses the custom electrodes. 
Fig. 3: In vitro tests of sensor components. a) Custom electrodes accurately measure standard media vs. a standard Ag/AgCl reference. b) Custom electrodes 
are resistant to external [Cl-] changes for short term exposure. c) Experiment setup for subfigure b. d) The IC measures and successfully transmits ORP 
wirelessly before and after encapsulation and packaging. e) Example of OOK data wirelessly recorded from the sensor in vitro. f) Measurement setup for 
subfigures d (pre-encapsulation) and e. g), h) Pre and post-aging piezo resistance and reactance profile respectively indicate the encapsulation is robust to 
aging. i) Measurement setup for impedance characterization. Note: all error bars shown represent the standard deviation. 
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The curves are very similar, showing that the sensor 
maintains linearity after packaging. A 35-code difference 
in offset and 1% difference in slope are attributed to the 
custom electrodes used for the specific sensor. The post-
packaging measurement further serves as a calibration 
curve, used in subsequent in vivo tests to interpret sensor 
outputs in unknown media (see “In vivo demonstration” 
section). 
 
C. Fabrication and encapsulation 
 It is important for an in vivo implant to be easily 
manufacturable for large-n rodent studies, as well as water 
impermeable and biocompatible for long-term operation 
in the body. To minimize local inflammation response and 
prevent infection, the implant should also able to 
withstand sterilization procedures. Additional constraints 
in our case include the need for the encapsulation material 
to be compatible with ultrasound transmission, and with 
surgical suturing techniques for fixing the implant 
position in the rodent cecum. The fabrication strategy 
adopted to meet these constraints is as follows. 
 First, the sensor electrical components (IC, capacitors, 
and piezo) are assembled on a thin (200 μm) FR4 Printed 
Circuit Board (PCB). The thickness was chosen so as to 
limit the device volume and provide some flexibility 
while retaining structural integrity for component 
placement and bonding. For ease of fabrication, only the 
top side of the PCB is populated; for further 
miniaturization, both sides could be utilized. The implant 
has four PCB via-holes that extend from the main body of 
the board (see Fig. 2a), which we refer to as ‘wings’. The 
via-holes on the wings accommodate a size 4:0 suture 
needle and allow attachment to the cecal epithelium. After 
assembly, the implants are tested as described in the 
“Electronics” section to verify functionality. The 
unencapsulated sensors are then cleaned via immersion in 
acetone, methanol, and isopropanol.  
 To provide water impermeability and biocompatibility, 
the implants are encapsulated in layers of 
Polydimethylsiloxane (PDMS) and Parylene C [52], [53]. 
PDMS is also advantageous because its acoustic 
impedance matches that of tissue [54]. A custom-designed 
aluminum mold holds the implant during PDMS curing, 
which lasts 48 hours (room temperature). The mold shape 
allows for complete encapsulation of the main body of the 
implant while leaving the electrode pads as well as the 
wings uncovered. The electrodes are attached with 
conductive epoxy, leaving the sensing tips protruding 
from the sensor body. An extra protective layer of 
nonconductive medical epoxy is then added on top of the 
electrode pads for biocompatibility and cured at 65 °C for 
an hour. Finally, the implants are coated with 6 μm of 
Parylene C. Since the Parylene C covers the sensor 
electrode tips, it is carefully removed to allow contact of 2 
mm of the electrodes with the medium. Before in vivo 
implantation, the implants are tested to produce the final 
calibration curve as mentioned previously. Implants are 
sterilized by autoclaving while submerged in 2.8 M KCl 
and left to rehydrate in the same sterile solution. The final 
post-encapsulation implant measures 20 x 5.6 x 4 mm3 
(Fig. 2a), allowing it to be implanted in a rat cecum with 
ease. 
 After validating the robustness of the electrodes and 
electronics in the previous sections, we separately tested 
the packaging robustness by fabricating a simplified 
sensor consisting of the piezo element only. 
Measurements of the piezo impedance and its changes 
through a polymer aging process were used as a test; 
major changes in the resistance and reactance values (e.g. 
indicative of a short) were interpreted as package failure 
and water ingress affecting the piezo component. To 
account for the presence of the electrode connections in 
the actual implant, the piezo terminals were internally 
wired to the implant electrode pads, which were 
connected to the impedance analyzer. Encapsulation and 
autoclave-sterilization were performed as described above 
and then an initial reference measurement of the piezo 
impedance was taken. Subsequently, the packaged ‘mock’ 
implant was immersed in a heated solution of saline 
(0.9%) for 24 hours to induce accelerated packaging aging 
and simulate the effects of in vivo implantation [55]. The 
aging solution temperature was 73 °C, giving a 12x 
acceleration [55] for total aging equivalent to a 12-day in 
vivo implantation. Afterward, a final measurement of 
impedance was taken and compared to the initial reference 
point. The results (Figs. 3g, 3h) indicate that the 
encapsulated piezo was negligibly affected by the aging 
procedure; the discrepancy is < 13% in the frequency 
region of interest, likely caused by movement in 
connection wires in the measurement setup (shown in Fig. 
3i). This suggests that the encapsulation materials can 
withstand at least 12 days of in vivo operation, protecting 
the implant electronics from degradation. 
  
D. Tests in fecal media and electronics input resistance        
 In the previous sections we report experiments for 
verification of the chip and electrode functionality in 
standard media. Biological media like the contents of the 
gut lumen are significantly more complex, containing 
digesta, sloughed epithelial cells, immune cells, and 
hundreds of bacterial species [56]. Because of this 
chemical complexity, the number of chemical species 
contributing to the ORP is likely significantly higher. 
ORP measurements have been used in soil science for 
several decades to predict environmental traits of 
relevance for agriculture and groundwater measurement. 
Two phenomena encountered in soil measurements of 
ORP are the dependence of measured ORP on measuring-
electronics impedance [17], [57], and the 
fouling/poisoning of the electrodes by biotic or abiotic 
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chemical factors. Here, we investigated whether these 
phenomena also appear in biological fecal media and how 
they might affect our in vivo measurements in rodent ceca.  
 To test the effect of impedance on ORP, we 
anaerobically incubated 3 Refex and polished platinum 
electrode pairs and one standard reference and polished 
platinum pair for 12 days in a fecal slurry (50-90% feces, 
50-10% PBS V/V in an anaerobic chamber with 
atmosphere N2:CO2:H2 80:15:5). Measurements with 
custom electrode pairs were started with a direct 
connection to a 1 TΩ ORP meter, (t = 0 to 0.2 hours) and 
then connected in parallel with a 17 MΩ resistor. The 
standard reference electrode pair was maintained at 1 ΤΩ 
as ground truth. At high impedance (t = 0) the Refex 
electrodes start within 20 mV of the standard reference 
(Fig. 4a inset). Upon connection to 17 MΩ resistance 
loading (setup shown in Fig. 4b), the ORP changes and 
over 12 days deviates ~300 mV from the ground truth, 
with a slow drift towards 0 (Fig. 4a); based on this result 
we verified that ORP measurements in feces depend on 
the impedance of the measuring equipment. 
  To determine whether the 12-day fecal exposure 
caused electrode fouling and permanent damage, 
especially under constant current draw due to low 
measurement resistance, we subsequently returned the 
custom electrodes to high impedance (1 TΩ) by removing 
the 17 MΩ resistor (Fig. 4a, at t = 264 hours). Within 22 
hours, the custom electrodes’ ORP recovered to within 30 
mV of the standard reference value (estimated asymptote 
using curve fitting; see supplementary Fig. S4). This 
indicates the electrode potential is, to first order, 
minimally affected by biofouling and extended electrical 
loading. Note that these results may be confounded by the 
custom electrode drift and offset due to medium [Cl-] as 
discussed in the electrodes section.  
 When the implant is immersed in the gut lumen, the 
electronics interact with electrodes both when they are off 
and when they are on (wirelessly powered). The front-end 
resistance was therefore measured over the entire input 
range in both off and on modes, using a sensitive current 
meter (Keysight B2962A). The worst case off-mode 
leakage was found to be 30 nA for -0.5 V inputs, and 3 nA 
in on-mode for the same input (supp. Fig. S2). This 
corresponds to approximately 17 MΩ impedance in off-
mode and 170 ΜΩ in on-mode. Therefore, the experiment 
results in Fig. 4a (“chip off”) also illustrate the worst-case 
effect of the implant electronics on ORP if the implant 
was powered off for 12 days in vivo. Note that the effect 
of the electronics input capacitance was neglected as a 
minor contributor to the overall response time constant. 
 Having established that the electrodes can maintain 
correct ORP with return to high impedance, we asked 
Fig. 4: a) Low measurement resistance (17 MΩ) causes higher custom electrode ORP, but the ORP recovers when the resistance is disconnected, despite 12 
days of fecal medium exposure. b) Measurement setup for subfig. a. c) Transitions in measurement resistance from 17 MΩ (electronics off mode) to 170 
MΩ (on mode) consistently result in an ORP closer to the unloaded measurement. d) Additional examples of short-time scale transitions in different fecal 
media. Top: loading using resistors. Bottom: using an actual IC connected to electrodes. e) Measurement setup for subfig. d, bottom. f) The transitions in 
measurement resistance can be modeled using a circuit model similar to the Randle circuit. 
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whether the implant on-mode resistance is high enough 
during wireless measurements to allow sufficient 
measurement accuracy. Repeating the above experiment 
in a different fecal matrix, for a Refex and Pt electrode 
pair we studied the transition from off mode to on mode, 
and then to an unloaded measurement (1 TΩ). We 
similarly conservatively modeled the chip using resistors 
of 170 ΜΩ for on-mode and 17 MΩ for off-mode. We 
repeated the resistance switch sequence 3 times within an 
8-day period (Fig. 4c). Here the on-mode settled value 
was consistently ~50 mV different from the unloaded 
value, indicating our implant would measure a higher 
ORP than a 1 TΩ instrument in this medium. The 
unloaded ORP itself was higher than that measured with a 
standard reference electrode and a different Pt at 1 TΩ, by 
~70 mV in 1 hour and ~25 mV in 22 hours (Fig. S5), 
which could be attributed to Refex electrode offset, 
differences in the individual fecal media in each of the 
containers, and changes to individual platinum electrodes.   
 We performed multiple repetitions of this experiment 
with short vs. long exposure of electrodes in fecal media 
as well as in stirred and unstirred conditions. An example 
of two short time scale experiments is shown in Fig. 4d. 
Here, similar behaviour was observed but with lower 
errors, with a modelled IC on-mode being ~20 mV 
different than the unloaded value (Fig. 4d top). We finally 
also used the implant itself in a benchtop setup (Fig. 4e) 
and wirelessly controlled its power up. We confirmed the 
behaviour in this case remained the same (Fig. 4d 
bottom).  
 Overall, we conclude that the prototype electronics 
will measure an ORP that is at an offset from the true 
value. This offset may vary with medium properties such 
as conductivity and flow, but in vitro measurements 
averaged ~0-70 mV for fresh/stirred media (see Fig. S6 
for additional examples) and up to ~120 mV for multi-day 
old/unstirred fecal matrices – including custom electrode 
offsets. These errors are within the variability reported in 
ORP literature2 and smaller than many ORP-associated 
phenotypes observed. For instance, a general purpose 
front end such as the present one could still be used to 
distinguish between conventional and streptomycin 
treated mice (~400 mV) [58], mono- vs. hexa-colonized 
mice (~225 mV) [59], conventional and germ-free rats 
(~300 mV) [35], and conventional and germ-free mice 
(~450 mV) [59]. Subtler phenotype differences could be 
measured by implementing a high input impedance buffer 
in the electronics front-end. 
 To derive intuition for the observed phenomena and 
guide the future design of improved electronics for this 
application, we implemented approximate electrical 
modelling of the electrode sensor using lumped elements. 
The transient responses we observed in the reported 
experiments in Fig. 4 tend to follow exponential decays 
and settling to a different voltage, implying the electrode 
electrical response is described by large RC time 
constants. Differences in measured ORP in stirred and 
unstirred media (example in Fig S6) suggest that mass 
transport of the redox active species in the fecal matter 
can also affect the electrode impedance. Notably, in test 
solutions (e.g. Zobell’s, Light’s), a 10 MΩ voltmeter will 
return the same value as a 1 ΤΩ meter suggesting that the 
electrode impedance in such media is lower (supplemental 
Fig. S7). The transient responses allow us to (i) predict 
their approximate final settled value using curve fitting, 
and to (ii) map the fitted responses to a simple circuit 
model similar to the Randle circuit (Fig. 4f). The model 
component values R1, R2, C can be derived based on the 
beginning and end voltages of the transient, as well as the 
measurement instrument resistance (see supp. Fig. S8). 
The accuracy of this model could be improved by taking 
into account 2nd order effects, such as the impact of 
medium diffusion (example curve fits using two 
exponential time constants are shown in Fig. S4). 
Analysis techniques such as Electrochemical Impedance 
Spectroscopy (EIS) could also be used in the future to 
model the electrode system in more detail. 
 
IV. IN VIVO DEMONSTRATION 
 To demonstrate the sensor’s ability to enable extended 
and convenient measurement of gut ORP in vivo, we 
implanted a fully functional sensor in a 12-week-old 
female Sprague Dawley rat. A second rat of the same age, 
sex, and breed was housed separately, did not receive an 
implant and served as a control to investigate possible 
effects of implantation. Animal handling was in 
accordance with a research protocol approved by the 
Institutional Animal Care and Use Committee (IACUC).  
 The animal receiving the implant was anesthetized 
using inhalant isoflurane titrated to effect (1.5-3%, 1-3 
L/min of 100% oxygen) and maintained on circulating 
warm water blanket during surgery. Pre-emptive analgesia 
was provided using buprenorphine SR (1 mg/kg SQ) and 
meloxicam (0.2 mg/kg SQ). Surgical instruments and the 
implant were autoclaved prior to the surgery. The 
abdomen was shaved and sterilized using 3x alternating 
swipes of alcohol and betadine. Laparotomy was then 
performed and the cecum was exteriorized, isolated using 
a sterile swab, and kept moist with sterile saline. A 1 cm 
incision was made in the tail of the cecum along greater 
curvature, ensuring that leakage of cecal contents was 
minimal (see Fig. 5a). The implant was gently placed at 
the wall of the cecum and fastened by sutures through the 
wings to the surrounding cecum epithelium (Fig. 5a and 
b), and then secured within the cecum with non-
absorbable suture in a continuous inverting pattern to 
close the cecal incision. The cecum was thoroughly rinsed 
to reduce contamination, and then replaced into the 
abdomen. The laparotomy was closed in 2 layers. Finally, 
the rat was monitored until fully recovered. Notably, by 
using a sterile implant and meticulous sterile technique, 
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we were able to avoid prophylactic antibiotic treatment of 
the implanted rat; this enables experiments in antibiotic 
naïve animals, which are critical for studying the 
microbiome. Similar technique may also enable 
implantation into germ-free animals, though the technical 
hurdles are larger. 
 The rat recovered under daily monitoring for 3 days 
until activity returned to a pre-surgery baseline. On day 4 
post surgery, an ORP measurement was taken and 
measurements continued at a frequency of approximately 
once every 2 days until day 12.  For all measurements, the 
rat was placed under inhalant isofluorane anaesthesia (1.5-
3%, 1-3 L/min of 100% oxygen) and kept on a warm 
blanket as above. Ultrasound gel was placed on the 
abdomen area and the ultrasonic transducer was gently 
placed on the rat skin (Fig. 5c). The device location was 
identified through gentle massage of the rat abdomen. 
Measurement lasted under 15 minutes, allowing for 
assembling the measurement setup, locating the sensor, 
and taking sufficient samples; afterward the rat was 
allowed to recover.   
 Captured sensor codes (example shown in Fig. 5d) 
were mapped to ORP using the previously measured post-
packaging calibration curve (Fig. 3c, in red). Similar 
transients were observed as in experiments in fecal 
matrices – as a result, the final values of the transients 
 
Fig. 5: In vivo procedures and results. a) Steps of implantation procedure: incision, opening of the cecum, placement of implant such that the electrodes 
point towards the head of the cecum without contacting the walls, and closure via suture. b) Sensor in the process of implantation and suturing in the rat 
cecum. c) Ultrasound measurement setup. d) Example of captured high SNR wireless signal from the sensor. e) Measured ORP from the implanted sensor 
over 12 days. f) Weight fluctuation throughout the experiment, remaining below the 10% humane endpoint. g) Healed incision 12 days after surgery, 
indicating surgical recovery and health. Note: scale bars shown in above photographs are approximate. 
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were used, as best estimates of the unloaded ORP (see 
supplemental Fig. S9 for example raw results).  The 
measurement results are shown in Fig. 5e. Our ORP 
measured range was approx. -470 mV to -320 mV. 
Immediately post-euthanasia, using a Pt and standard 
Ag/AgCl reference (Fig. S10), the implanted rat cecum 
ORP measured -380 mV to -200 mV and the control rat 
measured -407 mV to -218 mV, suggesting the impact of 
the implant itself on cecal ORP was minimal. Values 
ranged widely and depended on location in cecum and 
proximity to the atmosphere (see supplement Fig. S11 for 
a demonstration of ORP change in fecal media 
transitioned from anaerobic to aerobic conditions). 
Overall, the combined error from the implant input 
impedance and custom electrode [Cl-] dependence which 
we discussed in previous sections is likely on the order of 
100 mV. Nevertheless, literature values for ORP of 
exposed cecal content in sacrificed, anesthetized and 
ambulatory rats [34]–[36], and our own measurements 
broadly agree with our implant measured values. Note that 
in vivo ORP measurements in fully enclosed rat ceca have 
not been reported before, so no direct comparison is 
available.  
 Throughout the 12-day experiment, the rat weight 
fluctuation remained well below the defined humane 
endpoint of 10%, as shown in Fig. 5f, indicating the 
implant was well tolerated. Some variations in weight can 
be attributed to different times of measurement relative to 
the animal feeding cycle. Inspection of the surgical 
incision at the last day of measurement (Fig. 5g) also 
indicated undisturbed healing. The cecum itself appeared 
healthy (Fig. S12) without gross changes in shape or size.  
V. CONCLUSION 
 We have developed an in vivo oxidation-reduction 
potential implant sensor measuring 20 mm x 5.6 mm x 4 
mm and featuring wireless powerup and telemetry using 
ultrasound. The design and thorough characterization of 
electronics, packaging, and electrode materials enabled 
the prototype implant to survive standard autoclave 
sterilization and measure ORP for 12 days implanted in a 
rat cecum. This is the first implant able to produce 
longitudinal measurements of the ORP of a laboratory 
animal, enabling studies with alterations to diet, 
microbiome, and host genetics. While previous 
measurements of ORP have been conducted in laboratory 
animals, they have been almost exclusively terminal, 
preventing testing of most key experimental questions. 
 Our future work includes modifying the sensor 
electronics to produce a higher impedance measurement 
device and improving electrodes to reduce dependence on 
external [Cl-]. Combined, these changes should 
substantially lower the absolute error, allowing tests of 
subtle ORP phenotypes. Fabrication time can also be 
improved, allowing higher-n studies to measure the effect 
of diet, antibiotic, and microbiome composition on ORP.  
 Mechanistic insight into how ORP potentiates or 
ameliorates disease could lead to clinical translation by 
identifying patterns for diagnosis, and strategies for 
treatment, of diseases associated with redox imbalance 
(e.g. inflammatory bowel disease). While we believe ORP 
merits substantial investigation, the design and fabrication 
strategy of our implant is modular and could enable many 
other potentiometric electrochemical measurements (e.g. 
pH) in the gut. 
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SUPPLEMENTARY INFORMATION 
 
A. Materials 
 
All chemicals used were acquired from Sigma-Aldrich, with the exception of: Zobell’s, Modified Zobell’s and Light’s 
solutions obtained from Ricca Chemicals, PDMS Sylgard 184 from Dow Corning, Parylene C (Dichloro-p-cyclophane) from 
Specialty Coating Systems, nonconductive epoxy (FDA 2) from AA Bond, and conductive epoxy (Silver Epoxy) from MG 
Chemicals. For ORP vs. standard reference measurements in Fig. 3a and Fig. 3d, we used a SympHony SB70P pH meter in mV 
mode and a double junction Ag/AgCl reference electrode from Sigma-Aldrich. For the electrode characterization measurements 
in Fig. 3b, we used PCE-228 ORP loggers and Ag/AgCl reference electrodes (REDOX ORP-14, PCE Instruments). For ORP 
measurements in Fig. 4a-d we similarly used the PCE-228 ORP loggers; the traces labeled Pt vs. Std. ref. use the double junction 
Sigma-Aldrich Ag/AgCl electrode as reference. Platinum wires were acquired from SurepureChemetals (item 6044). The solid-
state reference electrodes (Refex) were fabricated at Refex Sensors Ltd. A Labcoter 2 PDS 2010 was used for Parylene C 
coating. All ultrasound measurements used the Olympus A303S transducer, Keysight 33500B Waveform generator and E&I 
Model 411LA power amplifier. Finally the Agilent Precision Impedance Analyzer 4294A was used for piezo impedance 
characterization and the Keysight B2962A for electronics resistance characterization. 
The pseudo-reference electrodes used in Fig. 3b were made using Dropsens C220AT screen printed Silver electrodes 
manually coated with an Ag/AgCl paste (ALS Co., Ltd). The paste was cured at 65 °C for 1 hour. PBS for the experiment also 
shown in Fig. 3b was prepared by diluting 10X stock to 1X with distilled water for a final concentration of 0.137 M NaCl, 
0.0027 M KCl, and 0.0119 M phosphates. 
 
B. Ultrasound transmission and data recovery 
 
Measurements involving implant ultrasound power up and data recovery used the A303S ultrasonic transducer with a 
focal distance of 3 cm. To maintain the implant piezo within the focal zone, a custom 2 cm long coupler filled with ultrasound 
gel was attached to the transducer resulting in a total transmission distance of 3 cm. To transmit ultrasound, we used the 
waveform generator, amplified by the power amplifier. Based on previous characterization of the transmitter’s beam profile, we 
estimate the peak acoustic intensity at the piezo at this distance to be 8.6 mW/mm2. For a repetition rate of 1 kHz, and a duty 
cycle of 12.7 % to 15.2 % (100 to 120 cycles of 790 kHz carrier), the time-averaged acoustic intensity is ≤ 1.3 mW/mm2 which is 
almost 6x below the FDA limit. Given our piezoelectric material area (1.08 mm x 1.08 mm), aperture efficiency (0.2 measured 
with a fully encapsulated device at 790 kHz), and above input acoustic intensity during charging, we calculate an available 
electrical power of 2 mW and an available energy of 278.5 nJ each power-up repetition (assuming 110 cycles of 790 kHz 
ultrasound carrier). The implant typically uses 131 nJ to operate, giving a power-up energy efficiency of 47%.   
A custom clipper diode-based transmit/receive switch was used to receive ultrasound signals from the implant after the 
end of power transmission. The captured data from the transducer were displayed and saved using the oscilloscope. The uplink 
data is encoded in OOK and consists of 10 bits. To interpret this data we performed OOK demodulation in Matlab using 
envelope detection and thresholding methods. The result is a code from 0 to 1023 (210-1), expected to map to an ORP voltage 
range of approximately -500 mV to 300 mV.   
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C. Supplementary figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S1: Implant average power consumption breakdown for a transmitted code 1111111111. The total average power was 152.5 μW from 
simulation. Since OOK modulation is used where the transmitter (TX) is turned off during bit 0, this represents the maximum power 
dissipation.    
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Fig. S2: Implant electronics front-end resistance characterization. a) Current-voltage plot for two implant ICs in powered off mode. b) 
Current-voltage plot for two implant ICs in powered on mode. In both cases the worst-case leakage current is observed for an input of -0.5 V. 
Our tests therefore use an equivalent resistance at this voltage value to simulate the effect of the chip on electrodes and ORP. Measurement 
details: a Keysight B2962A connected to the input leads of the implant was used to sweep the voltage and measure the current. Shielded 
insulated cables were used to minimize noise and cable leakage. At each 50 mV voltage increment, 100 measurements of the current were 
averaged together.  
 
Fig. S3: Conceptual diagram of the in vitro electronics measurement setup, after sensor encapsulation. The implant was powered and 
interrogated similarly to Fig. 3f (details in “Ultrasound transmission and data recovery” section). In this case the encapsulated implant was 
immersed directly in the calibration solution of interest. To compare to the sensor readout, a pair of standard ORP electrodes were also 
immersed in the medium and connected to the ORP voltmeter (not shown here). 
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Fig. S4: Estimation of exponential asymptote in ORP transients. The above traces correspond to the end of the experiments shown in Fig. 
4a, where t = 0 is the switch from low impedance loading (17 MΩ) to high impedance (1 TΩ). The Matlab curve fitting tool (cftool) was 
used to compute the above fits given the equation  ( ) =    ∗      +   ∗      +  . For t ∞,   ( ) =   and thus this term was used to 
estimate the settled values. a)   = −432.7, fit R2: 0.9865. b)   = −461.3, fit R2: 0.9916. c)    = −458.2, fit R2: 0.9698. 
 
Fig. S5: The extended last transition of the 8-day experiment of fecal immersion (Fig. 4c of the main text). The difference between the 
unloaded measurement of the custom electrode pair is seen to decrease over time. At 22 hours the electrode recovers to within 25 mV of the 
ground truth measurement.  
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Fig. S6: a) Example of impedance effect in stirred fecal media. Similar behavior is seen in unstirred media. Here the electronics on-mode was 
approximately 70 mV higher than the ground truth (standard reference measurement). b) Stirring is observed to result in a significantly 
different ORP, with values closer to the ground truth compared to an unstirred medium; this indicates electrode impedance is influenced by 
medium convection and flow.  
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Fig. S7: Three electrodes in ORP calibration media are measured with a PCE-228 1 TΩ logger and then loaded with a 10 MΩ resistor. The 
recorded ORP does not change, indicating the electrode impedance is significantly lower than in feces.   
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Fig. S8: Approximate modeling of electrode transient response due to a step in connected resistance. In a) (also Fig. 4f) a transition from a 1 
ΤΩ measurement resistance to a 17 MΩ resistance connected in parallel is shown. While not all transitions we have measured follow the 
same response (e.g. Fig. S4), the simple circuit in b) can often model the electrode system and measurement resistances well. Here RMEAS1 = 
1 TΩ, RMEAS2 = 17 MΩ and ORP, R1, R2 and C are electrode and medium related impedance parameters. Wire resistance/capacitance and 
other measurement/instrument capacitances were assumed to be negligible. 
The response of the circuit in b) can be expressed as: 
     ( ) =  
      ,                                                                        < 0 (            ℎ)
(     ,    −      ,  ) ∙  
 
 
  +      ,            > 0 (           ℎ)
,  
where      ,   ,      ,    and      ,   correspond to the measured voltage before the switch closes, the measured voltage right after the 
switch closes and the final settled voltage respectively, and τ is the system time constant. These are parameters that can be extracted directly 
from the experimentally measured response by curve fitting.  In the simplified case of RMEAS1 >> R1+R2 and RMEAS1>> RMEAS2, such as the 
one shown, they can be then mapped to the electrode and medium related parameters as follows: 
     ,    =     
     ,    =     ∙
      
       +   
 
     ,   =     ∙
      
       +    +   
 
  =   ∙ (       +   )||   =   ∙
(       +   ) ∙   
       +    +   
 
Solving for the model unknowns in this case we get ORP = -495 mV, R1 = 828 kΩ, R2 = 2.17 MΩ, C = 213 μF approximately. 
In cases where      ,    ≈      ,   , the model can be simplified by taking R1 = 0. 
This analysis could be generalized for arbitrary RMEAS1 and RMEAS2, and more complicated models could be developed for responses better 
fitted by two exponential time constants such as in Fig. S4. 
Note that while this process can be used to derive intuition for resistance transitions, despite the resemblance of the model to the Randle 
circuit, the derived parameters may not directly map to physical properties of the electrode and medium interface, such as the double layer 
capacitance and faradaic resistance. 
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Fig. S9:  Sample in vivo data vs. time. The raw binary data were demodulated to voltage using the post-encapsulation calibration curve 
shown in Fig. 3d. A Matlab script was used to log data of given length; due to the limitations of this script there are gaps in the data during 
which the data is saved. Nevertheless the data is seen to follow transient responses similar to those in in vitro tests due to limited input 
resistance.  
  
Fig. S10: Conceptual diagram of post-euthanasia ORP measurement. The standard ORP electrodes (platinum and Sigma Aldrich Ag/AgCl 
reference) are inserted in the incised and exposed rat cecum.  
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Fig. S11: Demonstration of the effect of atmospheric changes on ORP. a) A fecal slurry was incubated in an anaerobic chamber for 14 days 
and subsequently sealed in a container with ORP electrodes immersed in the medium, similarly to Fig. 4e. The tube was then moved to an 
aerobic environment and an opening was made, while the ORP was recorded. b) The results indicate that exchange of gas between media and 
atmosphere – likely loss of hydrogen from the media and ingress of oxygen – produces an increase in ORP.  
 
  
 
Fig. S12: Implant location in the rat cecum. The photo was taken during necropsy and indicates the rat intestines are healthy. Shown scale is 
approximate. 
